TCL Archive FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity? August 15, 1997
TCL Archive In Brief: George Vande Woude Of NCI Named PI for Litton Bionetics Basic Research Contract At Frederick September 23, 1983
TCL Archive Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center December 11, 1998